Systematic review and meta-analysis of the effect of intraoperative α₂-adrenergic agonists on postoperative behaviour

A Pickard1, P Davies2, K Birnie2

  • 1Department of Anaesthesia, Bristol Royal Children's Hospital, Bristol, UK ameliapickard@googlemail.com.

Insights

Intraoperative intravenous alpha-2 adrenergic agonists significantly reduce emergence delirium (ED) in children. While they may prolong recovery time, these drugs are safe and effective for managing postoperative behavioral changes.

Area of Science:

  • Pediatric Anesthesiology
  • Pharmacology
  • Behavioral Science

Background:

  • General anesthesia can cause distress in children, leading to behavioral issues like emergence delirium (ED).
  • Post-hospitalization behavioral changes are also a concern following pediatric surgical procedures.

Purpose of the Study:

  • To systematically review the impact of intraoperative intravenous (IV) alpha-2 adrenergic agonists on postoperative behavior in children.
  • To evaluate the efficacy of IV clonidine and dexmedetomidine in mitigating behavioral disturbances after anesthesia.

Main Methods:

  • A systematic review and meta-analysis of published randomized controlled trials (RCTs).
  • Included trials involved children receiving IV clonidine or dexmedetomidine post-anesthesia induction.
  • Data extraction and analysis focused on postoperative behavioral outcomes, including ED.

Main Results:

  • Strong evidence indicates IV alpha-2 adrenergic agonists significantly reduce the incidence of emergence delirium (ED) in children.
  • No studies investigated the effect of these agents on post-hospitalization behavioral changes.
  • A prolonged recovery room stay was observed, but deemed clinically insignificant.

Conclusions:

  • Intraoperative IV alpha-2 adrenergic agonists are effective in reducing emergence delirium (ED) in pediatric patients.
  • These agents demonstrate a favorable safety profile with no reported adverse hemodynamic events.
  • Further research is needed to assess the impact on post-hospitalization behavioral changes.

Related Concept Videos

Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
2.0K
General Anesthesia: Overview01:24

General Anesthesia: Overview

Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
1.1K
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
1.0K
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers01:22

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
1.7K
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
2.7K
Adrenergic Agonists: Therapeutic Classification01:18

Adrenergic Agonists: Therapeutic Classification

Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
1.8K